These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 167707)

  • 21. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
    Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
    Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live attenuated varicella vaccine in children with leukemia in remission.
    Gershon AA; Steinberg S; Galasso G; Borkowsky W; Larussa P; Ferrara A; Gelb L
    Biken J; 1984 Sep; 27(2-3):77-81. PubMed ID: 6100063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect and follow-up study on varicella vaccine.
    Katsushima N; Yazaki N; Sakamoto M
    Biken J; 1984 Sep; 27(2-3):51-8. PubMed ID: 6100058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection against varicella in family contacts by immediate inoculation with live varicella vaccine.
    Asano Y; Nakayama H; Yazaki T; Kato R; Hirose S
    Pediatrics; 1977 Jan; 59(1):3-7. PubMed ID: 190583
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of live varicella vaccine in children with acute leukemia and malignant lymphoma.
    Sato Y; Miyano T; Kawauchi K; Yokoyama M
    Biken J; 1984 Sep; 27(2-3):111-3. PubMed ID: 6100046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term protective immunity of recipients of the OKA strain of live varicella vaccine.
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Pediatrics; 1985 Apr; 75(4):667-71. PubMed ID: 2984636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of varicella vaccine.
    Takahashi M; Asano Y; Kamiya H; Baba K; Ozaki T; Otsuka T; Yamanishi K
    J Infect Dis; 2008 Mar; 197 Suppl 2():S41-4. PubMed ID: 18419406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination of children with malignant disease against varicella.
    Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of varicella vaccine in childhood leukemia. Observation over 6 years.
    Oka T; Iseki K; Oka R; Sakuma S; Yoshioka H; Takahashi M
    Biken J; 1984 Sep; 27(2-3):103-9. PubMed ID: 6100045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 4 serological tests--complement fixation, neutralization, fluorescent antibody to membrane antigen and immune adherence hemagglutination--for assay of antibody to varicella-zoster (V-Z) virus.
    Yamada A; Ogino S; Asano Y; Otsuka T; Takahashi M; Baba K; Yabuuchi H
    Biken J; 1979 Jun; 22(2):55-60. PubMed ID: 231433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of a live varicella vaccine to hospitalized children and its follow-up study.
    Katsushima N; Yazaki N; Sakamoto M; Fujiyama J; Nakagawa M; Okuyama Y; Takahashi M
    Biken J; 1982 Mar; 25(1):29-42. PubMed ID: 6289798
    [No Abstract]   [Full Text] [Related]  

  • 32. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
    Diaz PS; Au D; Smith S; Amylon M; Link M; Smith S; Arvin AM
    Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Worldwide experience with the Oka-strain live varicella vaccine.
    Andre FE
    Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 36. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
    [No Abstract]   [Full Text] [Related]  

  • 37. Live varicella vaccine in healthy individuals.
    Just M; Berger R; Luescher D
    Postgrad Med J; 1985; 61 Suppl 4():129-32. PubMed ID: 3014469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases.
    Konno T; Yamaguchi Y; Minegishi M; Goto Y; Tsuchiya S
    Biken J; 1984 Sep; 27(2-3):73-5. PubMed ID: 6100062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chickenpox vaccination of healthy children: immunological and clinical responses and protective effect in 1978-1982.
    Horiuchi K
    Biken J; 1984 Sep; 27(2-3):37-8. PubMed ID: 6100055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.